ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0297741 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Vinh Nguyen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of…. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Head and Neck Neoplasms, NF-E2-Related Factor 2, Transcription Factors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, NCI NIH HHS, NIEHS NIH HHS.
Abstract (Originalsprache)
Prior to the next generation sequencing and characterization of the tumor genome landscape, mutations in the SWI/SNF chromatin remodeling complex and the KEAP1-NRF2 signaling pathway were underappreciated. While these two classes of mutations appeared to independently contribute to tumor development, recent reports have demonstrated a mechanistic link between these two regulatory mechanisms in specific cancer types and cell models. In this work, we expand upon these data by exploring the relationship between mutations in BAF and PBAF subunits of the SWI/SNF complex and activation of NRF2 signal transduction across many cancer types. ARID1A/B mutations were strongly associated with NRF2 transcriptional activity in head and neck squamous carcinomas (HNSC). Many additional tumor types showed significant association between NRF2 signaling and mutation of specific components of the SWI/SNF complex. Different effects of BAF and PBAF mutations on the polarity of NRF2 signaling were observed. Overall, our results support a context-dependent functional link between SWI/SNF and NRF2 mutations across human cancers and implicate ARID1A inactivation in HPV-negative HNSC in promoting tumor progression and survival through activation of the KEAP1-NRF2 signaling pathway. The tumor-specific effects of these mutations open a new area of study for how mutations in the KEAP1-NRF2 pathway and the SWI/SNF complex contribute to cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America.
- Curriculum in Toxicology and Environmental Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America.
- Department of Otolaryngology, University of North Carolina, Chapel Hill, North Carolina, United States of America.
- Department of Cell Biology and Physiology, Washington University in St. Louis, St. Louis, Missouri, United States of America.
- Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America.
ORCID-Profile: Bernard E Weissman
Förderung
- NIDCR NIH HHS
- NCI NIH HHS
- NIEHS NIH HHS
- National Cancer Institute
- National Institute of Dental and Craniofacial Research
- National Institute of Environmental Health Sciences
Zitieren
APA
Nguyen, V., Schrank, T. P., Major, M. B., & Weissman, B. E. (2024). ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas. PLOS ONE. https://doi.org/10.1371/journal.pone.0297741
Vancouver
Nguyen V, Schrank TP, Major MB, Weissman BE. ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas. PLOS ONE. 2024. doi:10.1371/journal.pone.0297741
BibTeX
@article{Nguyen2024,
author = {Nguyen, Vinh and Schrank, Travis P and Major, Michael B and Weissman, Bernard E},
title = {ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0297741}
}
EUVIMED